Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer
Introduction
Date
08 Oct 2016Session
Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancerPresenters
Yuichiro OheAuthors
Y. OheAuthor affiliations
- Thoracic Oncology, National Cancer Center Hospital, 104-0045 - Tokyo/JP
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Treatment decisions at ALK TKI resistance
Presenter: Maurice Perol
Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer
Resources:
Slides
Webcast
Development of a nationwide genomic screening network for lung cancer with rare driver oncogenes and investigation of the mechanism of drug resistance
Presenter: Shingo Matsumoto
Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer
Resources:
Slides
Webcast
Conclusions and clinical perspectives
Presenter: Solange Peters
Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer
Resources:
Slides
Webcast